Start › Rak płuc › Waszyngton › Washington
Badania kliniczne dla Rak płuc w mieście Washington, DC
41 badań dla Rak płuc szuka uczestników w ośrodkach w mieście Washington i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekrutacjaZapraszamy zdrowych ochotników
- Walter Reed National Military Medical Center, Bethesda · 7 mi dalej
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RekrutacjaFaza 3
- George Washington University Medical Center, Washington D.C.
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekrutacjaFaza 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- i 1 więcej
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RekrutacjaFaza 3
- George Washington University Medical Center, Washington D.C.
Evaluation for NCI Surgery Branch Clinical Research Protocols
RekrutacjaBadanie obserwacyjne
- National Institutes of Health Clinical Center, Bethesda · 7 mi dalej
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RekrutacjaBadanie obserwacyjne
- National Institutes of Health Clinical Center, Bethesda · 7 mi dalej
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RekrutacjaBadanie obserwacyjne
- National Institutes of Health Clinical Center, Bethesda · 7 mi dalej
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
RekrutacjaBadanie obserwacyjne
- National Institutes of Health Clinical Center, Bethesda · 7 mi dalej
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RekrutacjaFaza 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi dalej
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi dalej
A Study of PHN-012 in Patients With Advanced Solid Tumors
RekrutacjaFaza 1
- PHN-012-001 Site, Washington D.C.
Collection of Blood From Patients With Cancer
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- National Institutes of Health Clinical Center, Bethesda · 7 mi dalej
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 mi dalej
- Maryland Oncology Hematology, P.A., Bethesda · 7 mi dalej
- Maryland Oncology Hematology, P.A., Largo · 11 mi dalej
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekrutacjaFaza 2
- Georgetown University, Washington D.C.
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekrutacjaFaza 3
- Washington DC Veterans Affairs Medical Center, Washington D.C.
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RekrutacjaFaza 2/3
- MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), Washington D.C.
- MEDSTAR Washington Hospital Center (MedStar Health Research Institute), Washington D.C.
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
RekrutacjaFaza 1/2
- MedStar Georgetown University Hospital, Washington D.C.
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekrutacjaFaza 1/2
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekrutacjaFaza 3
- Sibley Memorial Hospital, Washington D.C.
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- Walter Reed National Military Medical Center, Bethesda · 7 mi dalej
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekrutacjaFaza 1/2
- Avenzo Therapeutics Recruiting Site, Washington D.C.
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
RekrutacjaFaza 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi dalej
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekrutacjaFaza 3
- Sibley Memorial Hospital, Washington D.C.
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekrutacjaFaza 1/2
- National Institutes of Health, Bethesda · 7 mi dalej
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
RekrutacjaFaza 1
- Maryland Oncology Hematology, Calverton · 12 mi dalej
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RekrutacjaFaza 1/2
- Georgetown University Medical Center, Washington D.C.
Gilteritinib for the Treatment of ALK NSCLC
RekrutacjaFaza 1
- Georgetown University, Washington D.C.
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- National Institutes of Health Clinical Center, Bethesda · 7 mi dalej
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 mi dalej
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
RekrutacjaFaza 1/2
- Georgetown University Medical Center, Washington D.C.
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2/3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 mi dalej
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · 11 mi dalej
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Cancer Support Community Research & Training Institute, Washington D.C.
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekrutacjaFaza 1/2
- Sibley Memorial Hospital, Washington D.C.
Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
RekrutacjaFaza 3
- The George Washington University Hospital, Washington D.C.
Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
RekrutacjaFaza 2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
- Medstar Washington Hospital Center, Washington D.C.
Erector Spinae Block for Thoracic Surgery
RekrutacjaFaza 4
- The George Washington University, Washington D.C.
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
RekrutacjaBadanie obserwacyjne
- MedStar Georgetown University Hospital, Washington D.C.
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekrutacjaFaza 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekrutacjaBadanie obserwacyjne
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi dalej
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi dalej
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RekrutacjaZapraszamy zdrowych ochotników
- MedStar Health, Washington D.C.
Badania dla Rak płuc w innych miastach
- Houston, TX78 badań
- Boston, MA62 badań
- New York City, NY60 badań
- Los Angeles, CA45 badań
- Arlington, VA41 badań
- Chicago, IL41 badań
- Baltimore, MD40 badań
- Nashville, TN40 badań
- St. Louis, MO39 badań
- Columbus, OH37 badań
- Philadelphia, PA36 badań
- Seattle, WA33 badań
Inne badania w mieście Washington
- Nowotwory (wszystkie typy)58 badań
- Niedrobnokomórkowy rak płuca55 badań
- Rak piersi46 badań
- Nowotwór przerzutowy43 badań
- Rak prostaty38 badań
- Otyłość33 badań
- Rak jelita grubego i odbytnicy29 badań
- Choroby układu sercowo-naczyniowego28 badań
- Rak pęcherza moczowego26 badań
- Ostra białaczka szpikowa24 badań
- Rak jajnika23 badań
- Chłoniak23 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.